News for Healthier Living

Mount Sinai Researchers Pioneer First Targeted Therapy for Rare T-Cell Lymphoma After CAR T Treatment

A team of researchers from The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai has successfully treated a rare and aggressive T-cell lymphoma that developed after CAR T-cell therapy for multiple myeloma, marking a first in the field of hematologic cancer research.

August 21, 2025


August 21 2025

August 20 2025

August 19 2025

August 18 2025

August 17 2025

August 16 2025

August 15 2025

August 14 2025

August 13 2025

August 12 2025

August 11 2025

August 10 2025

August 9 2025

August 8 2025

August 7 2025